Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

23.00
Delayed Data
As of Feb 17
 +0.41 / +1.81%
Today’s Change
7.80
Today|||52-Week Range
37.69
+29.72%
Year-to-Date
No recent news for Albireo Pharma Inc.

Today’s Trading

Previous close22.59
Today’s open22.61
Day’s range21.52 - 23.50
Volume36,056
Average volume (3 months)32,148
Market cap$144.7M
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+30.30%
Earnings growth (this year)+63.04%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.21

Competitors

 Today’s
change
Today’s
% change
SMMTSummit Therapeutics ...-0.05-0.43%
AGTCApplied Genetic Tech...+0.15+1.89%
REPHRecro Pharma Inc-0.04-0.51%
VTLVital Therapies Inc+0.10+2.22%
Data as of 3:59pm ET, 02/17/2017

Financials

Last reporting dateFebruary 20, 2017
EPS forecast (this quarter)-$1.50
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Ronald H. Cooper
Chief Operating Officer
Jan Peter Mattsson
Corporate headquarters
Boston, Massachusetts

Forecasts


Search for Jobs